Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsSnorradottir, Asbjorg Osk
Isaksson, Helgi J
Kaeser, Stephan A
Skodras, Angelos A
Bragason, Birkir Thor
MetadataShow full item record
CitationBrain Res. 2013, 1535:106-14
AbstractHereditary Cystatin C Amyloid Angiopathy (HCCAA) is a rare genetic disease in Icelandic families caused by a mutation in the cystatin C gene, CST3. HCCAA is classified as a cerebral amyloid angiopathy and mutant cystatin C forms amyloid deposits in cerebral arteries resulting in fatal haemorrhagic strokes in young adults. The aetiology of HCCAA pathology is not clear and there is, at present, no animal model of the disease. The aim of this study was to increase understanding of the cerebral vascular pathology of HCCAA patients with an emphasis on structural changes within the arterial wall of affected leptomeningeal arteries. Examination of post-mortem samples revealed extensive changes in the walls of affected arteries characterised by deposition of extracellular matrix constituents, notably collagen IV and the proteoglycan aggrecan. Other structural abnormalities were thickening of the laminin distribution, intimal thickening concomitant with a frayed elastic layer, and variable reduction in the integrity of endothelia. Our results show that excess deposition of extracellular matrix proteins in cerebral arteries of HCCAA is a prominent feature of the disease and may play an important role in its pathogenesis.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to Brain research
- Parenchymal cystatin C focal deposits and glial scar formation around brain arteries in Hereditary Cystatin C Amyloid Angiopathy.
- Authors: Osk Snorradottir A, Isaksson HJ, Kaeser SA, Skodras AA, Olafsson E, Palsdottir A, Thor Bragason B
- Issue date: 2015 Oct 5
- Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.
- Authors: Snorradottir AO, Isaksson HJ, Ingthorsson S, Olafsson E, Palsdottir A, Bragason BT
- Issue date: 2017 Apr
- The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage.
- Authors: Olafsson I, Thorsteinsson L, Jensson O
- Issue date: 1996 Apr
- Molecular diagnosis of hereditary cystatin C amyloid angiopathy.
- Authors: Jonsdottir S, Palsdottir A
- Issue date: 1993 Apr
- Mutation in the cystatin C gene causes hereditary brain hemorrhage.
- Authors: Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O
- Issue date: 1989